Clinical Trials
3 trialsNCT02535650 2022-03-08
Study of Tipifarnib in Patients With Previously-Treated, Advanced, HRAS Mutant Urothelial Carcinoma
Samsung Medical Center
Phase 2 Unknown
NCT00510939 2009-08-14
HEMOS AML 0106
University of Bologna
Phase 2 Unknown
NCT00006199 2005-06-24
Study of the Farnesyl Transferase Inhibitor, R115777, in Combination With Topotecan (NYU 99-32)
National Center for Research Resources (NCRR)
Phase 1 Unknown